The Emergence of COVID-19 to Augment the DNA Sequencing Equipment and Services Market Growth

Next generation sequencing is any of several high-throughput methods to DNA sequencing using the concept of massively parallel processing. DNA sequencing equipment is widely used to determine the precise order of nucleotide within a DNA molecule. The equipment reports the text string in terms of the four bases namely thymine (T), adenine (A), cytosine (C), and guanine (G). DNA sequencing equipment is also capable of analyzing the light signals, which are originated from fluorochromes attached to nucleotides.

Request Here PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/355

Market Dynamics:

Favorable government initiatives to support for large-scale sequencing, advancements in next-generation sequencing (NGS) platforms, and rapid advancements in sequencing technology and bioinformatics are expected to augment the growth of the DNA sequencing equipment and services market. For instance, in 2020, Helix OpCo received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) for its Helix COVID-19 NGS Test for the detection of the infection.

The outbreak of COVID-19 (SARS-CoV-2) has offered many growth opportunities to market players, as well as many government and non-government organizations. For instance, in June 2020, Illumina received EUA for its COVIDSeq Test that is used to sequence the full genome of the virus. Moreover, in May 2020, Genetics of Mortality in Critical Care, Genomics England, and the National Health Service of U.K. teamed up with Illumina to generate whole-genome sequences of around 35,000 COVID-19 citizens in the U.K.

Furthermore, strategic initiatives undertaken by market players, to expand their presence, are expected to propel the growth of the DNA sequencing equipment and services market. For instance, in 2020, GenapSys raised around US$ 75 million to bring its tabletop DNA sequencer to Asia amid coronavirus outbreak.

Major Players: Abbott Laboratories, Agilent Technologies, Bayer Corporation, Beckman Coulter, Commonwealth Biotechnologies, GE Healthcare Life Sciences, Hamilton Thorne Biosciences, Johnson & Johnson, Microchip Biotechnologies, Pacific Biosciences, Siemens AG, Thermo Fisher Scientific Inc., and ZS Genetics.

Major players in the market are adopting various inorganic strategies, such as merger and collaboration, to strengthen their market position. For instance, in March 20221, RevoluGen, under its collaboration agreement with Tecan, announces the technology validation (by DNA sequencing) of the world’s first automated extraction of library-ready High Molecular Weight (HMW) DNA in a multi-well filter plate format.

In February 2021, SoftBank Group Corp announced to invest US$ 900 million into Pacific Biosciences to strengthen Pacific’s position in the long-read DNA sequencing market.

Buy Now with Discount for Premium Report With Flat US $ 2000 Off: – https://www.coherentmarketinsights.com/promo/buynow/355

More Related Reports:

North America & Europe Artificial Pancreas Systems Market - https://www.medgadget.com/2021/08/north-america-europe-artificial-pancreas-systems-market-2021-snapshot-industry-predict-a-long-term-growth-at-12-9-cagr-by-revenue-us-320-2-million-by-2027-coherent-market-insights.html

Europe Platelet rich Plasma Market - https://www.medgadget.com/2021/08/europe-platelet-rich-plasma-market-value-to-worth-over-us-75-8-million-at-7-1-cagr-growth-rate-technology-snapshot-with-solution-to-drive-market-growth-by-2027.html

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.